Literature DB >> 28866047

Mathematical models in cancer therapy.

Giuseppe Jordão1, João Nuno Tavares2.   

Abstract

In this article, deterministic mathematical models are derived from biochemical models within a human cell in two distinct cases, for comparison: healthy cell and cancerous cell. The former model is based in the cell cycle model by Novak and Tyson and its adaptation by Conradie, and makes use of the MAPK cascade pathway and the PI3K/AKT pathway for signalling transduction, to create a wider updated model for the regulation of a healthy cell. The latter model, for the cancer cell, is derived from the healthy cell model by altering specific pathways and interpreting the outcome in the light of literature in cancer. This last study is done in two approaches: simulation of common deregulations and specific cancer simulation, colon cancer. After studying both models, we propose targeting therapies and simulate their consequences. We thus explore mathematical modelling efficacy and usefulness in providing enough information from which to derive ideas for therapies. The purpose is to validate mathematics, once again, as a powerful tool with which one can model the underlying nature of chaotic systems and extract useful conclusions to real-life problems.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer therapies; Deregulation of a healthy cell; MAPK cascade pathway; Mathematical models; PI3K/AKT pathway

Mesh:

Substances:

Year:  2017        PMID: 28866047     DOI: 10.1016/j.biosystems.2017.08.007

Source DB:  PubMed          Journal:  Biosystems        ISSN: 0303-2647            Impact factor:   1.973


  2 in total

1.  Modeling and Analysis of Breast Cancer with Adverse Reactions of Chemotherapy Treatment through Fractional Derivative.

Authors:  Tao-Qian Tang; Zahir Shah; Ebenezer Bonyah; Rashid Jan; Meshal Shutaywi; Nasser Alreshidi
Journal:  Comput Math Methods Med       Date:  2022-02-12       Impact factor: 2.238

2.  Cell-Level Spatio-Temporal Model for a Bacillus Calmette-Guérin-Based Immunotherapy Treatment Protocol of Superficial Bladder Cancer.

Authors:  Teddy Lazebnik
Journal:  Cells       Date:  2022-08-02       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.